Click Here to return To Results

 

Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature JNNP 82:306-308, Benedetti,L.,et al, 2011 See this aricle in Pubmed Article Abstract Rituximab seems to be a promising therapeutic choice when it targets both CIDP and co-occuring haematological diseases. Timely post-onset administration of rituximab seems to be associated with better responses.

Related Tags

(click to filter results - removes previous filter) monoclonal antibodies polyneuropathy,chronic inflammatory demyelinating rituximab treatment of neurologic disorder

Click Here to return To Results